Dr. Lance S. Reinherz, MD

Dr. Reinherz practices at University Surgery Center Doctors Inc in Murrieta, California.

Dr. Reinherz's NPI, 1134173750, was assigned on May 19, 2006. Dr. Reinherz graduated from Universidad Autonoma de Guadalajara in 1996. Dr. Reinherz holds California license A86823.

Dr. Reinherz's primary practice is University Surgery Center Doctors Inc, at 25405 Hancock Ave, Murrieta, CA 92562 in Riverside County. The practice phone is (951) 677-2333.

Dr. Reinherz's primary practice is University Surgery Center Doctors Inc in Murrieta, California. Dr. Reinherz is also affiliated with Southwest Healthcare Rancho Springs Hospital. The medical group on file is Temecula Valley Cardiology. Dmand AI also links Dr. Reinherz to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reinherz practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Reinherz's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Reinherz is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Reinherz's licenses on file in 2 states: California and New York.

Dmand AI lists aneurysm, aortic atherosclerois, atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic embolism thrombosis, chronic hypertension and coronary artery disease among the conditions Dr. Reinherz treats.

CMS data shows 5,662 Medicare services from Dr. Reinherz across 36 procedure codes in 2024, for 823 Medicare patients. Medicare paid $353,506 for them.

CMS counts 823 Medicare patients who saw Dr. Reinherz in 2024. The largest group is 75 to 84, with 353 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Reinherz's median patient age at 77, with 56% women.

In 2024, Dr. Reinherz wrote 5,892 Medicare Part D claims for 573 patients. 87% of them were for generic drugs. CMS names the drug for 5,653 of them, across 61 drugs with 11 or more claims each, at $810,187 in total drug cost. In 2023, CMS named 5,426 claims across 58 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 76 out of 100 for Dr. Reinherz for performance year 2024, reported as part of a group. Dr. Reinherz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Reinherz as offering telehealth.

CMS Open Payments shows 210 general payments to Dr. Reinherz from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Novartis Pharmaceuticals Corporation paid the most, $698.

Dr. Reinherz graduated from Universidad Autonoma de Guadalajara in 1996. Dr. Reinherz is a member of ACC, AMA, ASE and NLA.

Dr. Reinherz is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.